Market Reach Belgian focus with a broad portfolio spanning branded medicines, OTC, generics and biosimilars, offering multiple entry points for hospital and retail channels across cardiovascular, GI, women's health, CNS, dermatology and vaccination.

Hospital Footprint Strong presence in Belgian hospitals with widespread adoption; leverage hospital relationships to upsell across product lines and introduce biosimilars and generics to reduce costs and improve formulary coverage.

Access & Volume Current impact of delivering 17 million medicine boxes annually to 11 million Belgians indicates capacity for high-volume supply agreements, cobranded campaigns, and long-term procurement contracts with public and private sector buyers.

Strategic Brands Well-known brands such as Lipanthyl, Epipen, Influvac and Brufen present opportunities for co-marketing, patient support programs, and expedited access initiatives in both hospital and community settings.

Growth Readiness Small to mid-size organization with 51-200 employees and revenue in the mid-range suggests agility for strategic partnerships, distribution deals, and pilot programs to expand into adjacent therapeutic areas and regional markets.